Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Salubris Pharmaceuticals Co., Ltd.
  6. News
  7. Summary
    002294   CNE100000FW8

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

(002294)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
10/25Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Month..
CI
10/07Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan ann..
CI
09/05Shenzhen Salubris Pharmaceuticals Co., Ltd. announces an Increase in Equity Buyback.
CI
08/23Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year ..
CI
07/25Shenzhen Salubris Pharmaceuticals Co., Ltd. announces an Equity Buyback for CNY 200 mil..
CI
07/25SHENZHEN SALUBRIS PHARMACEUTICALS CO : 002294) intends to launch an Equity Buyback Plan.
CI
07/25Shenzhen Salubris Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
CI
07/02Salubris Biotechnology Co., Ltd. announced that it expects to receive CNY 263.8 million..
CI
06/22Shenzhen Salubris Pharmaceuticals Co., Ltd. announced that it has received CNY 1.951871..
CI
06/14ROSY METRO LIMITED acquired a 13.78% stake in M.A. Med Alliance S.A from Shenzhen Salub..
CI
04/19Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quar..
CI
03/30NORTAI International Ltd. announced that it expects to receive $80 million in funding f..
CI
03/29Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year ..
CI
2020Shenzhen Salubris Biomedical Engineering Co., Ltd. announced that it has received CNY 3..
CI
2020Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan ann..
CI
More most relevant news
All news about SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
10/25Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Month..
CI
10/07Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan ann..
CI
09/05Shenzhen Salubris Pharmaceuticals Co., Ltd. announces an Increase in Equity Buyback.
CI
08/23Viracta Up 5% After It Reacquires Rights to Combination Therapy in China
DJ
08/23VIRACTA THERAPEUTICS : Reacquires Exclusive Rights to Combination Therapy Candidate for Ly..
MT
08/23Shenzhen Salubris Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year ..
CI
08/06SKILLFUL CRAFTSMAN EDUCATION TECHNOL : Names Dawei Chen as Chief Financial Officer
MT
07/25Shenzhen Salubris Pharmaceuticals Co., Ltd. announces an Equity Buyback for CNY 200 mil..
CI
07/25Shenzhen Salubris Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
CI
07/25SHENZHEN SALUBRIS PHARMACEUTICALS CO : 002294) intends to launch an Equity Buyback Plan.
CI
More news
News in other languages on SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
08/23Viracta Therapeutics récupère les droits exclusifs d'une combinaison thérapeutique pour..
08/06Skillful Craftsman Education Technology nomme Dawei Chen au poste de directeur financie..
More news
Press releases
2018SHENZHEN SALUBRIS PHARMACEUTICALS : Announces Investment and In-Licensing Agreement With M..
BU
More press releases
Upcoming event on SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
12/17/21